AbCellera Biologics

AbCellera to Collaborate with Biogen to Discover Therapeutic ...

About AbCellera Biologics Inc. AbCellera is breaking the barriers of conventional antibody drug discovery to bring better medicines to ...

AbCellera Biologics (Nasdaq:ABCL) - Stock Price, News & Analysis

Research AbCellera Biologics' (Nasdaq:ABCL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...

Vancouver's AbCellera more than doubles IPO target size, headed ...

Vancouver antibody developer AbCellera Biologics Inc. more than doubled the target size of its initial public offering Monday to as much as ...

AbCellera and Lilly to Co-develop Antibody Therapies for the ...

About AbCellera Biologics Inc. AbCellera is a privately held company that engages in partnerships to discover and develop next-generation ...

AbCellera Biologics Inc. et al v. Berkeley Lights, Inc., No ... - Justia Law

AbCellera Biologics Inc. et al v. Berkeley Lights, Inc., No. 4:2020cv08624 - Document 191 (N.D. Cal. 2024) case opinion from the Northern ...

AbCellera's success is unprecedented: what have we learned?

Vancouver-based AbCellera Biologics Inc. developed a microfluidic antibody screening platform, ancillary technologies, and a service-based ...

Abcellera Biologics Inc, 8QQ:HAM summary - FT.com - Markets data

AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine ...

Eli Lilly and Company, AbCellera Biologics, Amgen, AstraZeneca ...

RE: Eli Lilly and Company, AbCellera Biologics, Amgen, AstraZeneca, Genentech, and. GSK Expedited Business Review Request Pursuant to COVID ...

A Canadian biotech giant is born: AbCellera stock triples in ... - Darpa

An AbCellera Biologics Inc. scientist at work at one of the company's labs. ABCELLERA/COURTESY OF MANUFACTURER.. Page 2. The stock, which ...

AbCellera Biologics Inc. (ABCL) Latest News and Market updates

Stocks-ABCL-AbCellera Biologics Inc. ABCL AbCellera Biologics Inc. 2.73 ...

AbCellera Biologics Inc. Company & People | ABCL | Barron's

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes ...

Abcellera Biologics Inc - Reuters

Get Abcellera Biologics Inc (ABCL.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.

INSERTING and REPLACING AbCellera Named to Fast Company's ...

AbCellera is transforming the field of biologics, generating first-in-class drugs through partnerships with pharma and biotech companies and ...

AbCellera Biologics IPO of common shares - Lexpert

On Dec. 15, 2020, AbCellera Biologics Inc. (“AbCellera” or the “Company”) closed its underwritten initial public offering (the “Offering”) of 27772500 ...

AbCellera Biologics Describes Unprecedented Speed of Innovation

AbCellera Biologics Inc. became the first company in North America to receive a blood sample from a patient who had recovered from COVID-19.

AbCellera Biologics (NASDAQ:ABCL) Sees Strong Trading Volume

AbCellera Biologics Inc builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune ...

Cutting-edge antibody therapy firm, AbCellera, to lay off 10 per cent ...

... first antibody therapy treatment for COVID-19 has announced layoffs amounting to 10 per cent of its workforce. AbCellera Biologics Inc.

Stifel Reiterates Buy on AbCellera Biologics, Lowers Price Target to ...

Stifel analyst Stephen Willey reiterates AbCellera Biologics (NASDAQ:ABCL) with a Buy and lowers the price target from $14 to $12.

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Tops ... - Zacks

AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -16.67% and 6.76%, respectively, for the quarter ended March ...